Pediatric Oncology Focus RPRD Diagnostics is the pharmacogenomics reference laboratory for leading pediatric cancer centers, signaling strong credibility and partnerships potential with additional children's hospitals seeking precision medicine capabilities. Focus on expanding adoption of PGx panels including the CNT Panel for leukemia drug toxicity risk.

Cost Reduction Value Tests enable clinicians to tailor therapy and support decision making, with potential to reduce adverse events and treatment costs. Position RPRD's PGx services as a payer friendly, outcomes driven solution to expand adoption among hospitals and clinics.

Pharma Partnerships RPRD already serves pharmaceutical companies globally for PGx testing; opportunities exist to broaden collaboration on companion diagnostics, clinical trials, and tailored panels to support precision medicine programs in drug development and regulatory filings.

Strategic Hospital Expansion As a small, specialized lab, target mid sized hospital networks and regional health systems lacking in house PGx capabilities, leveraging current reference lab status to win multi site contracts and extend CNT Panel deployment.

Digital Lead Generation Capitalize on existing marketing channels such as LinkedIn Ads and Google Ads to generate clinician leads in oncology, pharmacogenomics, and laboratory services; develop education and case studies to improve outreach and conversion with potential partners.